AN2 Therapeutics Inc (ANTX)

AN2 Therapeutics Inc. experienced significant insider trading activity recently, characterized by substantial planned sales totaling over six million dollars. While one purchase occurred, the overall trend reflects heavy divestment by directors. These movements follow a period of stock price volatility and precede the upcoming quarterly results financiers, highlighting notable shifts in leadership equity positions.
Ticker: ANTX Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for AN2 Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.7
Eizen Joshua M See Remarks Officer
Transaction date
Planned sale
Price
31.02
Quantity 59,111 -15.3%
Value US$2,987,618
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Planned sale
Price
291.72
Quantity 94,073 +13.2%
Value US$1,177,427
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Planned sale
Price
352.60
Quantity 76,456 +36.1%
Value US$3,100,966
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Planned sale
Price
6.02
Quantity 5,294 -0.8%
Value US$31,861
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Planned sale
Price
6.02
Quantity 4,725 -0.8%
Value US$28,436
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Planned sale
Price
6.07
Quantity 3,223 -0.5%
Value US$19,563
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Planned sale
Price
6.07
Quantity 2,877 -0.5%
Value US$17,463
1.0
Williams Sarah Joanne Principal Accounting Officer Officer
Transaction date
Sale
Price
5.53
Quantity 272 -0.4%
Value US$1,504
2.0
FitzPatrick Margaret M Non-Executive Director
Transaction date
Purchase
Price
5.53
Quantity 2,098 +24.4%
Value US$11,602
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Planned sale
Price
6.01
Quantity 18,706 -2.9%
Value US$112,389
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Planned sale
Price
6.01
Quantity 16,696 -2.9%
Value US$100,313
2.7
Readnour Robin Shane Director Non-Executive Director
Transaction date
Proposed sale
Price
6.01
Quantity 1,012,000
Value US$6,080,268
1.7
Eizen Joshua M See Remarks Officer
Transaction date
Planned sale
Price
4.17
Quantity 5,945 -2.8%
Value US$24,803
1.0
Williams Sarah Joanne Principal Accounting Officer Officer
Transaction date
Sale
Price
4.43
Quantity 265 -0.4%
Value US$1,174
1.0
Williams Sarah Joanne Principal Accounting Officer Officer
Transaction date
Sale
Price
1.06
Quantity 327 -0.5%
Value US$347
1.7
Prior Stephen David Chief Strategy Officer Officer
Transaction date
Sale
Price
1.01
Quantity 2,858 -4.6%
Value US$2,892
Chanda Sanjay Chief Development Officer Officer
Transaction date
Planned sale
Price
1.01
Quantity 5,956 -7.3%
Value US$6,027
1.7
Eizen Joshua M See Remarks Officer
Transaction date
Sale
Price
1.01
Quantity 6,931 -4.3%
Value US$7,014
Day Lucy Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.01
Quantity 5,512 -6.8%
Value US$5,578
1.7
Prior Stephen David Chief Strategy Officer Officer
Transaction date
Sale
Price
1.00
Quantity 3,604 -5.5%
Value US$3,615
Chanda Sanjay Chief Development Officer Officer
Transaction date
Planned sale
Price
1.00
Quantity 3,295 -3.9%
Value US$3,305
1.7
Eizen Joshua M See Remarks Officer
Transaction date
Sale
Price
1.00
Quantity 17,923 -10.1%
Value US$17,948
Day Lucy Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.00
Quantity 3,295 -3.9%
Value US$3,305
1.7
Prior Stephen David Chief Strategy Officer Officer
Transaction date
Planned sale
Price
1.14
Quantity 765 -1.2%
Value US$872
1.7
Eizen Joshua M See Remarks Officer
Transaction date
Planned sale
Price
1.14
Quantity 2,819 -1.6%
Value US$3,214
4.1
Easom Eric Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.07
Quantity 10,000 +4.1%
Value US$10,665
2.9
Leonard Braden Michael Large shareholder
Transaction date
Sale
Price
1.03
Quantity 7,000 -0.2%
Value US$7,227
2.9
Leonard Braden Michael Large shareholder
Transaction date
Sale
Price
1.01
Quantity 425,000 -11.6%
Value US$429,250
2.9
Leonard Braden Michael Large shareholder
Transaction date
Sale
Price
1.09
Quantity 200,000 -6.2%
Value US$218,000
2.9
Leonard Braden Michael Large shareholder
Transaction date
Sale
Price
1.16
Quantity 100,000 -2.7%
Value US$116,000
2.9
Leonard Braden Michael Large shareholder
Transaction date
Sale
Price
1.16
Quantity 2,000,000 -34.8%
Value US$2,320,000
2.0
FitzPatrick Margaret M Non-Executive Director
Transaction date
Purchase
Price
1.18
Quantity 8,610 New position
Value US$10,133
Day Lucy Chief Financial Officer Officer
Transaction date
Planned sale
Price
1.34
Quantity 2,957 -8.3%
Value US$3,965
Chanda Sanjay Chief Development Officer Officer
Transaction date
Planned sale
Price
1.34
Quantity 2,957 -9.0%
Value US$3,965
1.7
Prior Stephen David Chief Strategy Officer Officer
Transaction date
Sale
Price
1.34
Quantity 2,029 -5.7%
Value US$2,721
1.7
Eizen Joshua M See Remarks Officer
Transaction date
Sale
Price
1.34
Quantity 9,663 -7.6%
Value US$12,958
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.49
Quantity 5,000 +0.8%
Value US$7,468
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.49
Quantity 5,000 +0.9%
Value US$7,462
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.43
Quantity 18,483 +2.9%
Value US$26,407
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.43
Quantity 12,289 +2.2%
Value US$17,577
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.45
Quantity 6,517 +1.0%
Value US$9,427
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.45
Quantity 12,711 +2.3%
Value US$18,367
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.42
Quantity 25,000 +4.2%
Value US$35,418
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.42
Quantity 25,000 +4.7%
Value US$35,422
4.3
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
1.40
Quantity 2,000 +1.6%
Value US$2,800
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.39
Quantity 12,500 +2.1%
Value US$17,428
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.39
Quantity 12,500 +2.4%
Value US$17,418
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.15
Quantity 25,000 +5.1%
Value US$28,870
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.16
Quantity 25,000 +4.5%
Value US$29,000
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.04
Quantity 75,000 +18.1%
Value US$77,730
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Purchase
Price
1.03
Quantity 75,000 +15.5%
Value US$77,528
4.3
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
1.01
Quantity 5,000 +4.2%
Value US$5,050
4.3
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
1.00
Quantity 20,000 +20.4%
Value US$19,996
4.1
Easom Eric Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.00
Quantity 50,000 +4.9%
Value US$49,970
Transaction date
Proposed sale
Price
1.00
Quantity 1,699,998
Value US$1,699,999
2.9
Leonard Braden Michael Large shareholder
Transaction date
Purchase
Price
1.04
Quantity 1,500,000 +35.3%
Value US$1,560,000
4.3
Zakrzewski Joseph S Non-Executive Director
Transaction date
Sale
Price
19.11
Quantity 100,000 -19.8%
Value US$1,911,410
4.3
Z3 TRUST Director Non-Executive Director
Transaction date
Proposed sale
Price
19.11
Quantity 100,000
Value US$1,911,410
3.7
Aziz Kabeer Non-Executive Director
Transaction date
Sale
Price
19.65
Quantity 15,907 -4.0%
Value US$312,573
3.7
Aziz Kabeer Non-Executive Director
Transaction date
Sale
Price
19.65
Quantity 84,093 -4.0%
Value US$1,652,427
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Planned sale
Price
21.91
Quantity 719 -0.1%
Value US$15,753
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Planned sale
Price
21.92
Quantity 706 -0.2%
Value US$15,476
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Planned sale
Price
21.92
Quantity 1,800 -0.4%
Value US$39,456
2.7
Readnour Robin Shane Non-Executive Director
Transaction date
Planned sale
Price
21.93
Quantity 1,869 -0.4%
Value US$40,987
Transaction date
Proposed sale
Price
21.53
Quantity 9,443
Value US$203,308
Krause Kevin Michael Chief Strategy Officer Officer
Transaction date
Planned sale
Price
20.14
Quantity 7,417 -79.5%
Value US$149,367
Krause Kevin Michael Chief Strategy Officer Officer
Transaction date
Planned sale
Price
20.12
Quantity 2,583 -57.4%
Value US$51,967
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-06 2026-11-05 PlS Planned sale

See Remarks

Officer
59,111 -15.3%
31.02
US$2,987,618
59,111 -15.3% 31.02 US$2,987,618
2026-09-11 2026-09-09 PlS Planned sale Non-Executive Director
94,073 +13.2%
291.72
US$1,177,427
94,073 +13.2% 291.72 US$1,177,427
2026-09-11 2026-09-09 PlS Planned sale Non-Executive Director
76,456 +36.1%
352.60
US$3,100,966
76,456 +36.1% 352.60 US$3,100,966
2026-09-08 2026-09-08 PlS Planned sale Non-Executive Director
5,294 -0.8%
6.02
US$31,861
5,294 -0.8% 6.02 US$31,861
2026-09-08 2026-09-08 PlS Planned sale Non-Executive Director
4,725 -0.8%
6.02
US$28,436
4,725 -0.8% 6.02 US$28,436
2026-09-08 2026-09-03 PlS Planned sale Non-Executive Director
3,223 -0.5%
6.07
US$19,563
3,223 -0.5% 6.07 US$19,563
2026-09-08 2026-09-03 PlS Planned sale Non-Executive Director
2,877 -0.5%
6.07
US$17,463
2,877 -0.5% 6.07 US$17,463
2026-09-04 2026-09-01 S Sale

Principal Accounting Officer

Officer
272 -0.4%
5.53
US$1,504
272 -0.4% 5.53 US$1,504
2026-09-02 2026-09-01 B Purchase Non-Executive Director
2,098 +24.4%
5.53
US$11,602
2,098 +24.4% 5.53 US$11,602
2026-08-19 2026-08-17 PlS Planned sale Non-Executive Director
18,706 -2.9%
6.01
US$112,389
18,706 -2.9% 6.01 US$112,389
2026-08-19 2026-08-17 PlS Planned sale Non-Executive Director
16,696 -2.9%
6.01
US$100,313
16,696 -2.9% 6.01 US$100,313
2026-08-17 2026-08-17 PrS Proposed sale

Director

Non-Executive Director
1,012,000
6.01
US$6,080,268
1,012,000 6.01 US$6,080,268
2026-07-10 2026-07-08 PlS Planned sale

See Remarks

Officer
5,945 -2.8%
4.17
US$24,803
5,945 -2.8% 4.17 US$24,803
2026-06-02 2026-05-29 S Sale

Principal Accounting Officer

Officer
265 -0.4%
4.43
US$1,174
265 -0.4% 4.43 US$1,174
2026-03-05 2026-03-03 S Sale

Principal Accounting Officer

Officer
327 -0.5%
1.06
US$347
327 -0.5% 1.06 US$347
2026-01-07 2026-01-06 S Sale

Chief Strategy Officer

Officer
2,858 -4.6%
1.01
US$2,892
2,858 -4.6% 1.01 US$2,892
2026-01-07 2026-01-06 PlS Planned sale

Chief Development Officer

Officer
5,956 -7.3%
1.01
US$6,027
5,956 -7.3% 1.01 US$6,027
2026-01-07 2026-01-06 S Sale

See Remarks

Officer
6,931 -4.3%
1.01
US$7,014
6,931 -4.3% 1.01 US$7,014
2026-01-07 2026-01-06 PlS Planned sale

Chief Financial Officer

Officer
5,512 -6.8%
1.01
US$5,578
5,512 -6.8% 1.01 US$5,578
2026-01-07 2026-01-05 S Sale

Chief Strategy Officer

Officer
3,604 -5.5%
1.00
US$3,615
3,604 -5.5% 1.00 US$3,615
2026-01-07 2026-01-05 PlS Planned sale

Chief Development Officer

Officer
3,295 -3.9%
1.00
US$3,305
3,295 -3.9% 1.00 US$3,305
2026-01-07 2026-01-05 S Sale

See Remarks

Officer
17,923 -10.1%
1.00
US$17,948
17,923 -10.1% 1.00 US$17,948
2026-01-07 2026-01-05 PlS Planned sale

Chief Financial Officer

Officer
3,295 -3.9%
1.00
US$3,305
3,295 -3.9% 1.00 US$3,305
2025-11-06 2025-11-04 PlS Planned sale

Chief Strategy Officer

Officer
765 -1.2%
1.14
US$872
765 -1.2% 1.14 US$872
2025-11-06 2025-11-04 PlS Planned sale

See Remarks

Officer
2,819 -1.6%
1.14
US$3,214
2,819 -1.6% 1.14 US$3,214
2025-06-03 2025-06-02 B Purchase

Chief Executive Officer

Executive Director
10,000 +4.1%
1.07
US$10,665
10,000 +4.1% 1.07 US$10,665
2025-05-30 2025-05-30 S Sale Large shareholder
7,000 -0.2%
1.03
US$7,227
7,000 -0.2% 1.03 US$7,227
2025-05-30 2025-05-30 S Sale Large shareholder
425,000 -11.6%
1.01
US$429,250
425,000 -11.6% 1.01 US$429,250
2025-06-16 2025-05-28 S Sale Large shareholder
200,000 -6.2%
1.09
US$218,000
200,000 -6.2% 1.09 US$218,000
2025-05-30 2025-05-28 S Sale Large shareholder
100,000 -2.7%
1.16
US$116,000
100,000 -2.7% 1.16 US$116,000
2025-05-30 2025-05-28 S Sale Large shareholder
2,000,000 -34.8%
1.16
US$2,320,000
2,000,000 -34.8% 1.16 US$2,320,000
2025-05-29 2025-05-28 B Purchase Non-Executive Director
8,610 New position
1.18
US$10,133
8,610 New position 1.18 US$10,133
2025-01-07 2025-01-03 PlS Planned sale

Chief Financial Officer

Officer
2,957 -8.3%
1.34
US$3,965
2,957 -8.3% 1.34 US$3,965
2025-01-07 2025-01-03 PlS Planned sale

Chief Development Officer

Officer
2,957 -9.0%
1.34
US$3,965
2,957 -9.0% 1.34 US$3,965
2025-01-07 2025-01-03 S Sale

Chief Strategy Officer

Officer
2,029 -5.7%
1.34
US$2,721
2,029 -5.7% 1.34 US$2,721
2025-01-07 2025-01-03 S Sale

See Remarks

Officer
9,663 -7.6%
1.34
US$12,958
9,663 -7.6% 1.34 US$12,958
2024-12-10 2024-12-10 B Purchase Non-Executive Director
5,000 +0.8%
1.49
US$7,468
5,000 +0.8% 1.49 US$7,468
2024-12-10 2024-12-10 B Purchase Non-Executive Director
5,000 +0.9%
1.49
US$7,462
5,000 +0.9% 1.49 US$7,462
2024-12-10 2024-12-09 B Purchase Non-Executive Director
18,483 +2.9%
1.43
US$26,407
18,483 +2.9% 1.43 US$26,407
2024-12-10 2024-12-09 B Purchase Non-Executive Director
12,289 +2.2%
1.43
US$17,577
12,289 +2.2% 1.43 US$17,577
2024-12-10 2024-12-06 B Purchase Non-Executive Director
6,517 +1.0%
1.45
US$9,427
6,517 +1.0% 1.45 US$9,427
2024-12-10 2024-12-06 B Purchase Non-Executive Director
12,711 +2.3%
1.45
US$18,367
12,711 +2.3% 1.45 US$18,367
2024-11-27 2024-11-27 B Purchase Non-Executive Director
25,000 +4.2%
1.42
US$35,418
25,000 +4.2% 1.42 US$35,418
2024-11-27 2024-11-27 B Purchase Non-Executive Director
25,000 +4.7%
1.42
US$35,422
25,000 +4.7% 1.42 US$35,422
2024-11-27 2024-11-27 B Purchase Non-Executive Director
2,000 +1.6%
1.40
US$2,800
2,000 +1.6% 1.40 US$2,800
2024-11-27 2024-11-26 B Purchase Non-Executive Director
12,500 +2.1%
1.39
US$17,428
12,500 +2.1% 1.39 US$17,428
2024-11-27 2024-11-26 B Purchase Non-Executive Director
12,500 +2.4%
1.39
US$17,418
12,500 +2.4% 1.39 US$17,418
2024-11-21 2024-11-20 B Purchase Non-Executive Director
25,000 +5.1%
1.15
US$28,870
25,000 +5.1% 1.15 US$28,870
2024-11-21 2024-11-20 B Purchase Non-Executive Director
25,000 +4.5%
1.16
US$29,000
25,000 +4.5% 1.16 US$29,000
2024-11-21 2024-11-19 B Purchase Non-Executive Director
75,000 +18.1%
1.04
US$77,730
75,000 +18.1% 1.04 US$77,730
2024-11-21 2024-11-19 B Purchase Non-Executive Director
75,000 +15.5%
1.03
US$77,528
75,000 +15.5% 1.03 US$77,528
2024-11-20 2024-11-19 B Purchase Non-Executive Director
5,000 +4.2%
1.01
US$5,050
5,000 +4.2% 1.01 US$5,050
2024-11-20 2024-11-18 B Purchase Non-Executive Director
20,000 +20.4%
1.00
US$19,996
20,000 +20.4% 1.00 US$19,996
2024-11-18 2024-11-18 B Purchase

Chief Executive Officer

Executive Director
50,000 +4.9%
1.00
US$49,970
50,000 +4.9% 1.00 US$49,970
2024-08-15 2024-08-15 PrS Proposed sale

Affiliate

1,699,998
1.00
US$1,699,999
1,699,998 1.00 US$1,699,999
2024-08-15 2024-08-15 PrS Proposed sale

Affiliate

299,999
1.02
US$305,998
299,999 1.02 US$305,998
2024-08-14 2024-08-14 B Purchase Large shareholder
1,500,000 +35.3%
1.04
US$1,560,000
1,500,000 +35.3% 1.04 US$1,560,000
2024-08-13 2024-08-09 S Sale Large shareholder
114,759 -27.6%
1.08
US$123,940
114,759 -27.6% 1.08 US$123,940
2024-08-13 2024-08-09 S Sale Large shareholder
3,410,335 -66.4%
1.08
US$3,683,162
3,410,335 -66.4% 1.08 US$3,683,162
2024-01-19 2024-01-18 S Sale Non-Executive Director
100,000 -19.8%
19.11
US$1,911,410
100,000 -19.8% 19.11 US$1,911,410
2024-01-18 2024-01-18 PrS Proposed sale

Director

Non-Executive Director
100,000
19.11
US$1,911,410
100,000 19.11 US$1,911,410
2024-01-18 2024-01-16 S Sale Non-Executive Director
15,907 -4.0%
19.65
US$312,573
15,907 -4.0% 19.65 US$312,573
2024-01-18 2024-01-16 S Sale Non-Executive Director
84,093 -4.0%
19.65
US$1,652,427
84,093 -4.0% 19.65 US$1,652,427
2024-01-18 2024-01-16 S Sale Large shareholder
15,907 -4.0%
19.65
US$312,573
15,907 -4.0% 19.65 US$312,573
2024-01-18 2024-01-16 S Sale Large shareholder
84,093 -4.0%
19.65
US$1,652,427
84,093 -4.0% 19.65 US$1,652,427
2024-01-16 2024-01-16 PrS Proposed sale

Shareholder

15,907
20.88
US$332,138
15,907 20.88 US$332,138
2024-01-16 2024-01-16 PrS Proposed sale

Shareholder

84,093
20.88
US$1,755,862
84,093 20.88 US$1,755,862
2024-01-17 2024-01-12 PlS Planned sale Non-Executive Director
719 -0.1%
21.91
US$15,753
719 -0.1% 21.91 US$15,753
2024-01-17 2024-01-12 PlS Planned sale Non-Executive Director
706 -0.2%
21.92
US$15,476
706 -0.2% 21.92 US$15,476
2024-01-12 2024-01-10 PlS Planned sale Non-Executive Director
1,800 -0.4%
21.92
US$39,456
1,800 -0.4% 21.92 US$39,456
2024-01-12 2024-01-10 PlS Planned sale Non-Executive Director
1,869 -0.4%
21.93
US$40,987
1,869 -0.4% 21.93 US$40,987
2024-01-10 2024-01-10 PrS Proposed sale

Officer

Officer
9,443
21.53
US$203,308
9,443 21.53 US$203,308
2024-01-10 2024-01-10 PrS Proposed sale

Officer

Officer
11,033
21.53
US$237,540
11,033 21.53 US$237,540
2024-01-11 2024-01-09 PlS Planned sale

Chief Strategy Officer

Officer
7,417 -79.5%
20.14
US$149,367
7,417 -79.5% 20.14 US$149,367
2024-01-04 2024-01-02 PlS Planned sale

Chief Strategy Officer

Officer
2,583 -57.4%
20.12
US$51,967
2,583 -57.4% 20.12 US$51,967

See older AN2 Therapeutics Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock AN2 Therapeutics Inc history with Plus

Billed monthly · Cancel anytime